Updated October 1, 2026.
Decentralized science (DeSci) uses blockchain-based coordination, tokenized intellectual property, open communities, and alternative funding mechanisms to support scientific research. The term covers several different models, so it is important to distinguish donating to research, funding a research proposal, and acquiring an economic or governance interest connected with scientific intellectual property.
Platforms and models worth examining
VitaDAO
VitaDAO is focused on longevity and early-stage biotechnology. Its public research page reports funding across IP-NFT, equity, and initiative structures. Some projects use tokenized intellectual-property mechanisms intended to connect scientific development, governance, and potential downstream economic rights.
Best fit: people specifically interested in longevity biotechnology and willing to evaluate scientific, legal, token, liquidity, and execution risk.
Molecule
Molecule develops infrastructure for tokenizing and financing scientific intellectual property. Its model has included IP-NFTs and Science IP Tokens, with the stated aim of making research IP easier to fund, govern, and commercialize on-chain.
Best fit: researchers, biotech teams, DAOs, and sophisticated participants interested in the infrastructure linking research funding with intellectual-property rights. The exact legal and economic rights depend on the specific project and structure.
ResearchHub
ResearchHub is better described as an open-science funding and incentive platform than as an investment platform. It supports research proposals, bounties, peer review, replication, discussion, and ResearchCoin-based incentives. Its funding area includes requests for proposals and researcher-created proposals.
Best fit: people who want to fund research or participate in an open scientific incentive system without necessarily acquiring an ownership interest in a scientific venture.
Funding is not the same as investing
Many DeSci projects use tokens, but a token does not automatically represent equity, revenue rights, or ownership of intellectual property. Governance tokens may provide voting rights without a financial claim. Donation-based or bounty-based systems may provide no investment return at all. Some IP-linked structures may create economic rights, but those rights depend on contracts, jurisdiction, securities law, and the specific token architecture.
Before committing money, check:
- what legal entity receives the funds;
- whether you are donating, buying a token, buying equity, or acquiring some other contractual right;
- what intellectual-property rights, if any, are attached;
- whether the offering is legally available in your jurisdiction;
- how decisions are governed;
- whether there is meaningful liquidity or any realistic exit mechanism;
- what scientific milestones and reporting obligations exist;
- how conflicts of interest are disclosed.
Where Science DAO fits
Science DAO’s current flagship system, AI Internet-Meritocracy (AIIM), is an experimental research-funding mechanism, not an investment product. It is designed to allocate donated funds to researchers and open-source contributors using AI-assisted evaluation of documented contributions. Its next major evidence milestone is a proposed five-month adversarial test.
For the project’s current claims, limitations, and test plans, see the Testing & Evidence hub and Transparency page.
Bottom line
For direct exposure to tokenized scientific IP, VitaDAO and Molecule illustrate the most relevant DeSci models in this list. For open funding and scientific incentives without necessarily acquiring an investment interest, ResearchHub is a different but important model. These systems should not be treated as interchangeable: the legal rights, scientific risk, governance, liquidity, and expected return can differ substantially.
Disclosure: Science DAO operates in the broader DeSci ecosystem and is discussed above only to clarify its role. This article is informational and is not financial, legal, or investment advice.
Help Turn AIIM’s Beta into Evidence
AIIM remains experimental. The next proposed milestone is a five-month public adversarial test, with $1,000 planned for distribution to eligible funding recipients. Donations support the work required to run and evaluate that test.
Fund the public test → Test proposal → Independent review →
AI-generated evaluations can contain factual errors or biases; decentralized governance and non-custodial components remain under development. Public testing, auditability, and external criticism remain part of the project.